ArticleBioMed research international2026
Mapping the Research Growth and Citation Impact of Scholarly Works on Sickle Cell Disease in Tanzania: A Scientometric Study.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mapping the Research Growth and Citation Impact of Scholarly Works on Sickle Cell Disease in Tanzania: A Scientometric Study.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Sickle cell disease (SCD) remains a major public health concern in Tanzania, where research efforts associated with the Muhimbili Sickle Cell (MSC) Program have contributed to increased scientific output. However, there is limited consolidated evidence on bibliometric trends and research influence in this field. This study examined publication trends, authorship patterns, institutional contributions, and citation-based research influence of SCD research in Tanzania. A bibliometric analysis was conducted using publications retrieved from Dimensions, Scopus, Web of Science, and Google Scholar for SCD research involving Tanzanian scholars, covering 2003-2024. Records were included if they were peer-reviewed (articles/reviews) and/or scholarly publications indexed in the selected databases, included at least one author affiliated with a Tanzanian institution, and focused on SCD/hemoglobinopathies or related anemia conditions in Tanzania. English-language, full-text, accessible records were included, whereas studies unrelated to Tanzania-focused SCD or hemoglobinopathies, editorials, opinion pieces, letters, duplicates, records lacking full texts or bibliographic information, or those outside the timeframe were excluded. Google Scholar was used to capture additional records and citation signals that may not be uniformly indexed in other databases. Data were extracted, cleaned, and analyzed using Microsoft Excel, whereas VOSviewer and OriginPro were used for network mapping and visualization. Findings show a progressive/steady increase in SCD research output, with a peak in 2022 and the highest citation accumulation in 2023, indicating growing visibility of recent work. The most productive institutions were MUHAS, NIMR, and CUHAS, and key contributors included Makani J., Nkya S. W., and Sangeda R. Z. High-impact journals included PLOS One, Malaria Journal, and Blood. The thematic distribution of research output was mainly concentrated in clinical medicine, immunology, and biochemistry. The study demonstrates sustained growth in research visibility and impact in Tanzania, while showing that productivity remains concentrated among a limited number of institutions and authors, highlighting the need for broader participation and thematic diversification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.